No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

A. Ciccullo; A. Dusina; A. P. Lassandro; A. Borghetti; G. Baldin; Simona Di Giambenedetto

doi:10.1097/QAD.0000000000002495

No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

A. Ciccullo^*
, A. Dusina
, A. P. Lassandro
, A. Borghetti
, G. Baldin
, Simona Di Giambenedetto

^*Autore corrispondente per questo lavoro

Mater Olbia Hospital

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A Not Available

Lingua originale	Inglese
pagine (da-a)	956-957
Numero di pagine	2
Rivista	AIDS
Volume	34
Numero di pubblicazione	6
DOI	https://doi.org/10.1097/QAD.0000000000002495
Stato di pubblicazione	Pubblicato - 2020

All Science Journal Classification (ASJC) codes

Immunologia e Allergia
Immunologia
Malattie Infettive

Keywords

3-Ring
Adipose Tissue
Anti-HIV Agents
HIV Infections
Heterocyclic Compounds
Humans
Lamivudine
Oxazines
Piperazines
Pyridones
Weight Gain

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1097/QAD.0000000000002495

Altri file e collegamenti

Cita questo

@article{0d5286306ec54f379aa0512bda2dc77a,

title = "No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir",

abstract = "N/A Not Available",

keywords = "3-Ring, Adipose Tissue, Anti-HIV Agents, HIV Infections, Heterocyclic Compounds, Humans, Lamivudine, Oxazines, Piperazines, Pyridones, Weight Gain, 3-Ring, Adipose Tissue, Anti-HIV Agents, HIV Infections, Heterocyclic Compounds, Humans, Lamivudine, Oxazines, Piperazines, Pyridones, Weight Gain",

author = "A. Ciccullo and A. Dusina and Lassandro, \{A. P.\} and A. Borghetti and G. Baldin and \{Di Giambenedetto\}, Simona",

year = "2020",

doi = "10.1097/QAD.0000000000002495",

language = "English",

volume = "34",

pages = "956--957",

journal = "AIDS",

issn = "0269-9370",

publisher = "- Wolters Kluwer Health, Inc. -London : Lippincott Williams \& Wilkins -London : Gower Academic Journals, 1987-",

number = "6",

}

TY - JOUR

T1 - No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

AU - Ciccullo, A.

AU - Dusina, A.

AU - Lassandro, A. P.

AU - Borghetti, A.

AU - Baldin, G.

AU - Di Giambenedetto, Simona

PY - 2020

Y1 - 2020

N2 - N/A Not Available

AB - N/A Not Available

KW - 3-Ring

KW - Adipose Tissue

KW - Anti-HIV Agents

KW - HIV Infections

KW - Heterocyclic Compounds

KW - Humans

KW - Lamivudine

KW - Oxazines

KW - Piperazines

KW - Pyridones

KW - Weight Gain

KW - 3-Ring

KW - Adipose Tissue

KW - Anti-HIV Agents

KW - HIV Infections

KW - Heterocyclic Compounds

KW - Humans

KW - Lamivudine

KW - Oxazines

KW - Piperazines

KW - Pyridones

KW - Weight Gain

UR - https://publicatt.unicatt.it/handle/10807/193265

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85083541697&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083541697&origin=inward

U2 - 10.1097/QAD.0000000000002495

DO - 10.1097/QAD.0000000000002495

M3 - Article

SN - 0269-9370

VL - 34

SP - 956

EP - 957

JO - AIDS

JF - AIDS

IS - 6

ER -

No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo